Welcome to the e-CCO Library!

search
                             
search by: 
Filter:
Are stem cells ready for clinical practice?
Source: Webcast - ECCO'12 Barcelona Congress
Authors: Gijs Van der Brink
Are we ready to manage the microbiome?
Source: Webcast - ECCO'12 Barcelona Congress
Authors: Arlette Darfeuille-Michaud
Assessing endoscopic and disease activity in practice
Source: Webcast - ECCO'12 Barcelona Congress
Authors: Gert van Assche
Assessment of disease activity
Source: Webcast - ECCO 2015 Barcelona Congress - ECCO-ESGAR MRI Workshop "ECCO-ESGAR MRI Workshop 3: Session 2: Assessment of disease activity (Keywords: anti-TNF, ECCO, IBD, MRI, ultrasonography)
Authors: Stuart Taylor
Awards and closing remarks
Source: Webcast - ECCO 2015 Barcelona Congress - Scientific session 12: ECCO Lecture
Authors: Séverine Vermeire
Awards and Closing remarks
Source: Webcast - ECCO 2013 Vienna Congress - Awards and Closing remarks
Authors: Simon Travis
Awards and closing remarks
Source: Webcast - ECCO 2016 Amsterdam Congress - Scientific session 12: ECCO Lecture
Authors: Julián Panés
Basic principles of histological IBD diagnosis
Source: Webcast - ECCO 2016 Amsterdam Congress - 1st H-ECCO IBD Masterclass: Session 1: Basic aspects of IBD Pathology (Keywords: IBD, CD, UC, histopathology)
Authors: Roger Feakins
Best abstract 3: Development of a web-based application to improve quality of life in IBD patients
Source: Webcast - ECCO 2015 Barcelona Congress - 9th N-ECCO Network Meeting: Session 3: Are we optimising our options? Investigation and interpretation (Keywords: IBD, IBDQ, nurse, faecal incontinence, app, toilet)
Authors: Francisca Murciano Gonzalo
Best abstract: Long-term outcomes in a cohort of patients with Acute Severe Ulcerative Colitis refractory to intravenous steroids treated with cyclosporine or infliximab
Source: Webcast - ECCO 2015 Barcelona Congress - Scientific Session 7: ECCO Fellowships and Grants (Keywords: AZA,colectomy, cyclosporine, UC, infliximab)
Authors: Laharie David
Best abstract: Oral delivery of a new class of non-antibody protein scaffold nanofitins targeting TNF-alpha shows a strong preventive and curative anti-inflammatory effect in models of Inflammatory Bowel Diseases
Source: Webcast - ECCO 2015 Barcelona Congress - Scientific session 11: Managing the manageable: Chronic pain and fatigue
Authors: Mathieu Cinier
Best abstract: Patients with Inflammatory Bowel Disease and a history of cancer: The risk of cancer following exposure to immunosuppression
Source: Webcast - ECCO 2015 Barcelona Congress - Scientific session 9: What’s new on the guideline front? (Keywords: mercaptopurine, adalimumab, adenocarcinoma, anti-TNF, AZA, cancer, cancer in ibd, certolizumab, IBD, CD, UC, immonusuppressive agents, infliximab, lymphoma, methotrexate)
Authors: Jordan Axelrad
Best abstract: Post-operative use of anti-TNFa agents in patients with Crohn’s Disease and risk of re-operation – A nationwide cohort study
Source: Webcast - ECCO 2015 Barcelona Congress - Scientific session 11: Managing the manageable: Chronic pain and fatigue (Keywords: adalimumab, IBD, infliximab)
Authors: Jens Kjeldsen
Best abstract: 16S rRNA gene pyrosequencing indicate that siblings of Crohn's Disease patients exhibit a biologically relevant dysbiosis in the mucosal microbiota communities
Source: Webcast - ECCO 2014 Copenhagen Congress - Scientific session 10: Colitis under the microscope: Best abstract: 16S rRNA gene pyrosequencing indicate that siblings of Crohn's Disease patients exhibit a biologically relevant dysbiosis in the mucosal microbiota communities (Keywords: environmental factors, environmental risk factors, IBD, CD, siblings, dysbiosis, microbiota)
Authors: Charlotte Hedin
Best abstract: 52-week clinical efficacy with Adalimumab in patients with Moderatly to Severely Active Ulcerative Colitis who failed corticosteroids and/or immunosuppressants
Source: Webcast - ECCO 2011 Dublin Congress - Scientific Session 6: Daily challenges in IBD
Authors: Walter Reinisch
Best abstract: A multicentre, double-blind, placebo-controlled phase3 study of ustekinumab, a human interleukins-12/23p40 mab, in moderate-severe Crohn’s Disease refracto-ry to anti-TNFα: UNITI-1
Source: Webcast - ECCO 2016 Amsterdam Congress - Scientific session 5: Challenging dogmas – from clinical trials to clinical practice (Keywords: IBD, CD, ustekinumab)
Authors: Paul Rutgeerts
Best abstract: A phase III randomised controlled trial of Cx601, expanded allogeneic adipose-derived mesenchymal stem cells (eASC), for complex perianal fistulae in Crohn’s Disease
Source: Webcast - ECCO 2016 Amsterdam Congress - Scientific session 1: Cell therapy: Ready for clinical practice? (Keywords: fistula, CD, trials, cell therapy)
Authors: Julián Panés
Best abstract: A randomised, double-blind placebo-controlled phase 2a induction study of MEDI2070 (anti-p19 antibody) in patients with active Crohn’s Disease who have failed anti-TNF antibody therapy
Source: Webcast - ECCO 2015 Barcelona Congress - Scientific session 10: New therapies and strategies (Keywords: clinical trials, CD)
Authors: Bruce E. Sands
Best abstract: A randomised, double-blind, placebo- controlled induction trial of an oral S1P receptor modulator (RPC1063) in moderate to severe Ulcerative Colitis: Results of the TOUCHSTONE study
Source: Webcast - ECCO 2015 Barcelona Congress - Scientific session 10: New therapies and strategies
Authors: William Sandborn
Best abstract: A variable number of tandem repeat polymorphism in the promotor region of the neonatal Fc receptor affects anti-TNF serum levels in IBD
Source: Webcast - ECCO 2016 Amsterdam Congress - Scientific session 2: Application of genetic testing in understanding and managing IBD (Keywords: adalimumab, anti-TNF, biologic treatment, gentic, IBD, CD, UC, infliximab, pharmacogenomics, pharmacokinetics, trough levels, neonatal FC receptors)
Authors: Thomas Billiet